Vol. 13. Núm. 45.
Páginas 2617-2626 (Noviembre 2021)

Fibrilación auricular

Atrial fibrillation

P. Sánchez-BorqueaL. Bravo CaleroaA. Miracle BlancoaC. García-TalaveraaA. Porta SánchezbJ.A. Cabrera RodríguezbJ.M. Rubio Campala
Doi : https://10.1016/j.med.2021.11.001
Opciones
Resumen

La fibrilación auricular y el flutter o aleteo auricular son dos tipos de arritmias muy frecuentes en la población general, tanto en pacientes con cardiopatía estructural como en pacientes sin ella. Aunque desde el punto de vista fisiopatológico son entidades diferentes, comparten muchas características entre sí (factores predisponentes, riesgo cardioembólico, tratamiento) y, en muchas ocasiones, ambas arritmias pueden coexistir en un mismo paciente.

Palabras clave
Fibrilación auricular
Flutter o aleteo auricular
Fisiopatología
Manifestaciones clínicas
Diagnóstico
Tratamiento
Abstract

Atrial fibrillation and atrial flutter are two types of arrhythmias that are very common in the general population, both in patients with structural cardiopathy and patients without it. Although they are different entities from a physiopathological point of view, they have many characteristics in common (predisposing factors, cardioembolic risk, treatment) and, on many occasions, both arrhythmias may coexist in the same patient.

Keywords
Atrial fibrillation
Atrial flutter
Physiopathology
Clinical manifestations
Diagnosis
Treatment

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
E.
202111140747599318
202111140747599319
Arbelo, S. Aktaa, A. Bollmann, A. D’Avila, I. Drossart, J. Dwight, et al.
Quality indicators for the care and outcomes of adults with atrial fibrillation.
Europace., (2021), 23 pp. 494-495
[2]
M.
2021111407475993110
2021111407475993111
Brambatti, S.J. Connolly, M.R. Gold, C.A. Morillo, A. Capucci, C. Muto, et al.
ASSERT Investigators. Temporal relationship between subclinical atrial fibrillation and embolic events.
Circulation, (2014), 129 pp. 2094-2129
[3]
H.
2021111407475993112
2021111407475993113
Calkins, G. Hindricks, R. Cappato, Y.H. Kim, E.B. Saad, L. Aguinaga, et al.
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.
Europace., (2018), 20 pp. 157-208
[4]
The ESC Textbook of cardiovascular medicine, 3ª ed., Oxford University Press,
[5]
A.J.
2021111407475993116
2021111407475993117
Camm, E. Simantirakis, A. Goette, G.Y. Lip, P. Vardas, M. Calvert, et al.
Atrial high-rate episodes and stroke prevention.
Europace., (2017), 19 pp. 169-179
[6]
S.J.
2021111407475993118
2021111407475993119
Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, et al.
RE-LY Steering. Committee Investigators. Dabigatran versus warfarin in patients with atrial fibrillation.
N Engl J Med., (2009), 361 pp. 1139-1151
[7]
R.P.
2021111407475993120
2021111407475993121
Giugliano, C.T. Ruff, E. Braunwald, S.A. Murphy, S.D. Wiviott, J.L. Halperin, et al.
ENGAGE AF-TIMI Investigators. Edoxaban versus warfarin in patients with atrial fibrillation.
N Engl J Med., (2013), 369 pp. 2093-2104
[8]
A.
2021111407475993122
2021111407475993123
Goette, J.M. Kalman, L. Aguinaga, J. Akar, J.A. Cabrera, S.A. Chen, et al.
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.
Europace., (2016), 18 pp. 1455-1490
[9]
C.B.
2021111407475993124
2021111407475993125
Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, et al.
ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med., (2011), 365 pp. 981-992
[10]
M.
2021111407475993126
2021111407475993127
Haïssaguerre, P. Jaïs, D.C. Shah, A. Takahashi, M. Hocini, G. Quiniou, et al.
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
N Engl J Med., (1998), 339 pp. 659-666
[11]
G.
2021111407475993128
2021111407475993129
Hindricks, T. Potpara, N. Dagres, E. Arbelo, J.J. Bax, C. Blomström-Lundqvist, et al.
ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
Eur Heart J., (2021), 42 pp. 373-498
[12]
L.
2021111407475993130
2021111407475993131
Macle, M. Mansour, F.E. Marchlinski, G.F. Michaud, H. Nakagawa, A. Natale, et al.
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.
Europace., (2018), 20 pp. 157-208
[13]
G.
2021111407475993132
2021111407475993133
Michaud, W. Stevenson.
Atrial fibrillation.
Engl J Med., (2021), 384 pp. 353-361
[14]
M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, et al.
ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
N Engl J Med., (2011), 365 pp. 883-891
[15]
M.
2021111407475993134
2021111407475993135
Proietti, G.F. Romiti, B. Olshansky, D.A. Lane, G.Y.H. Lip.
Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) Pathway.
Am J Med., (2018), 131 pp. 1359-1369